California-based Hycor Biomedical Inc. plans to move its headquarters to central Indiana, creating as many as 20 jobs in the next two years, state economic development officials announced Wednesday morning.
The Indianapolis-based health insurer earned $2.44 per share and raised its full-year profit forecast by 40 cents per share.
Genzyme Corp., the drugmaker bought by Sanofi-Aventis SA this month, sued Zimmer Holdings Inc. and Anika Therapeutics Inc. alleging the companies’ treatments for arthritic knee pain infringe a patent.
Eli Lilly and Co. plans to use an implantable drug-delivery system made by Medtronic Inc. to precisely target patients' brains with an experimental drug for Parkinson’s disease.
Indiana taxpayers are paying about $300 million a year in nursing home costs despite a state law that would allow the state to save millions while keeping many elderly and disabled Hoosiers in their homes or with family members.
Anthem Blue Cross and Blue Shield’s vision for accountable care organizations foresees doctors and hospitals shifting to global capitation payments and employers getting bigger discounts if they allow their workers access only to health care providers in a specific organization.
Indiana Tobacco Prevention and Cessation, formed in 2001 and funded by money from a settlement with the tobacco industry, may be consolidated into the state Department of Health as a budget-cutting measure.
Carl Cook has been tabbed to replace his father, Bill Cook, who died a week ago. But many in the Bloomington business community know little about him, which reflects the company’s strict privacy policy.
The Indiana Senate approved a bill Tuesday that would cut off funding to Planned Parenthood and give the state some of the country's tightest abortion restrictions.
The Indiana House has approved a bill requiring criminal background checks for anyone seeking a new license to be a doctor, dentist or several other health care jobs.
The Indianapolis-based institutional pharmacy, which serves long-term-care facilities, wants to expand its business nationally.
The Indiana Senate voted Monday to prohibit any state contracts or grants with Planned Parenthood or other organizations that provide abortions.
A proposal that would have weakened Eli Lilly and Co.’s defenses against an unwanted takeover failed to pass Monday despite a large majority of shareholders voting to remove those barriers for the second straight year.
Eli Lilly and Co.’s first-quarter profit beat the expectations of Wall Street analysts, but its stock price slipped anyway Monday morning, along with the broader market.
First-quarter profit fell at Eli Lilly and Co. as the company recorded restructuring charges due to its downsizing and higher research costs as it tries to develop new drugs to help it shrug off its looming patent expirations.
Indiana Tobacco Prevention and Cessation officials acknowledge they still have work to do in a state that in 2008 had the nation's highest smoking rate and still has more than 1 million smokers.
Eli Lilly and Co. Inc. said Friday that the FDA has asked the drugmaker to conduct another clinical trial of its proposed pancreas drug before it resubmits an application to have the drug approved for sale.
The drug awaits final action by the European Commission, which has the authority to approve medicines for the European Union. The Commission usually makes a decision on CHMP recommendations within two to three months.
Physicians, dentists, nurses, veterinarians, pharmacists and other medical workers would have to undergo a criminal background check when applying for a new state license under a bill approved Tuesday by an Indiana House committee.
Officials from Indiana Medicaid and a hospital trade group are trying to craft a deal that would create a tax on hospitals that would help attract more federal funds for hospitals—thereby offsetting looming cuts in state payments.
